Compare BY & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BY | PAHC |
|---|---|---|
| Founded | 1914 | 1946 |
| Country | United States | United States |
| Employees | 1027 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.4B |
| IPO Year | 2017 | 2014 |
| Metric | BY | PAHC |
|---|---|---|
| Price | $38.40 | $39.06 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 4 |
| Target Price | $43.20 | ★ $44.00 |
| AVG Volume (30 Days) | 201.4K | ★ 201.9K |
| Earning Date | 10-22-2026 | 11-04-2026 |
| Dividend Yield | ★ 1.47% | 1.21% |
| EPS Growth | 5.09 | ★ 104.20 |
| EPS | 1.73 | ★ 2.43 |
| Revenue | N/A | ★ $833,350,000.00 |
| Revenue This Year | $4.37 | $3.87 |
| Revenue Next Year | $3.96 | $3.56 |
| P/E Ratio | $21.91 | ★ $16.43 |
| Revenue Growth | N/A | ★ 4.12 |
| 52 Week Low | $26.39 | $28.25 |
| 52 Week High | $40.05 | $60.08 |
| Indicator | BY | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 60.47 | 59.27 |
| Support Level | $37.82 | $38.29 |
| Resistance Level | $39.18 | $40.65 |
| Average True Range (ATR) | 0.74 | 1.45 |
| MACD | 0.20 | 0.18 |
| Stochastic Oscillator | 76.03 | 61.36 |
Byline Bancorp Inc is the holding company for Byline Bank, a full-service commercial bank serving small-and-medium sized businesses, financial sponsors, and consumers. The company offers a broad range of banking products and services to small and medium sized businesses, commercial real estate and online account opening to consumer and business. Also provide trust and wealth management services to its customers. In addition to traditional commercial banking business, company provide small ticket equipment leasing solutions through a wholly-owned subsidiary of Byline Bank.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.